Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
OPRX OptimizeRx Corp
- Stocks
- Healthcare
- NASDAQ: OPRX
Price (delayed)
$12.9
Market cap
$238.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.84
Enterprise value
$254.81M
OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients
Highlights
The gross profit is up by 27% year-on-year
OptimizeRx's EPS has increased by 24% from the previous quarter and by 18% YoY
OPRX's equity is down by 5% year-on-year
OptimizeRx's quick ratio has decreased by 2.9% QoQ
Key stats
What are the main financial stats of OPRX
Market
Valuations
Earnings
Shares outstanding
18.5M
Market cap
$238.59M
Enterprise value
$254.81M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.05
Price to sales (P/S)
2.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.7
Revenue
$94.37M
Gross profit
$60.52M
Operating income
-$10.79M
Net income
-$15.41M
EBIT
-$10.2M
EBITDA
-$5.85M
Free cash flow
$6.25M
Per share
Balance sheet
Liquidity
EPS
-$0.84
EPS diluted
-$0.84
Free cash flow per share
$0.34
Book value per share
$6.29
Revenue per share
$5.11
TBVPS
$2.84
Total assets
$167.77M
Total liabilities
$51.5M
Debt
$32.8M
Equity
$116.27M
Working capital
$33.36M
Debt to equity
0.28
Current ratio
2.82
Quick ratio
2.69
Net debt/EBITDA
-2.78
Margins
Efficiency
Dividend
EBITDA margin
-6.2%
Gross margin
64.1%
Net margin
-16.3%
Operating margin
-11.4%
Return on assets
-9.1%
Return on equity
-13.1%
Return on invested capital
-19.2%
Return on capital employed
-6.8%
Return on sales
-10.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
OPRX stock price
How has the OptimizeRx stock price performed over time
Intraday
-0.62%
1 week
-3.73%
1 month
10.73%
1 year
24.28%
YTD
165.43%
QTD
48.96%
Financial performance
How have OptimizeRx's revenue and profit performed over time
Revenue
$94.37M
Gross profit
$60.52M
Operating income
-$10.79M
Net income
-$15.41M
Gross margin
64.1%
Net margin
-16.3%
OPRX's operating margin has surged by 63% year-on-year and by 23% since the previous quarter
The operating income has soared by 56% YoY and by 21% from the previous quarter
The net margin is up by 29% year-on-year and by 25% since the previous quarter
The gross profit is up by 27% year-on-year
Price vs fundamentals
How does OPRX's price correlate with its fundamentals
Growth
What is OptimizeRx's growth rate over time
Valuation
What is OptimizeRx stock price valuation
P/E
N/A
P/B
2.05
P/S
2.53
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.7
OptimizeRx's EPS has increased by 24% from the previous quarter and by 18% YoY
The price to book (P/B) is 71% more than the last 4 quarters average of 1.2 but 51% less than the 5-year quarterly average of 4.2
OPRX's equity is down by 5% year-on-year
The stock's P/S is 68% below its 5-year quarterly average of 7.9 but 58% above its last 4 quarters average of 1.6
OPRX's revenue is up by 21% year-on-year and by 2.4% since the previous quarter
Efficiency
How efficient is OptimizeRx business performance
OptimizeRx's ROS has soared by 62% YoY and by 25% from the previous quarter
The ROIC is up by 45% year-on-year and by 22% since the previous quarter
The return on assets rose by 24% year-on-year and by 22% since the previous quarter
The return on equity rose by 22% since the previous quarter and by 13% year-on-year
Dividends
What is OPRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for OPRX.
Financial health
How did OptimizeRx financials performed over time
The total assets has declined by 4.9% year-on-year
OPRX's total liabilities is down by 4.9% since the previous quarter and by 4.3% year-on-year
The debt is 72% smaller than the equity
The debt has declined by 10% year-on-year
OPRX's debt to equity is down by 7% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.